Aim  and Vision

The aim of “Functional Genomics” in MOMA is a functional characterization of new cancer biomarkers and the investigation of their mode of action as well as their pathway involvement.
This will result in a better understanding of the molecular mechanisms triggering the development and progression of cancer.

PuzzleOur vision is the functional characterization of potential new diagnostic or prognostic biomarkers or potential therapy targets and the survey of their potential usability in clinics.

Moreover, we aim at mapping the complex intracellular network controlling cellular behaviour as e.g. invasive growth or formation of metastases.

All these issues shall address a more rational treatment  and e.g. tailor suited therapies for cancer patients in the future.

Future Research Activities

Future studies will focus on the functional characterization of clinical relevant genes and microRNAs dysregulated in bladder cancer, colorectal cancer and prostate cancer. 




Karin Birkenkamp-Demtröder
MSc, PhD, Associate professor

email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +45 784 55371